MAPT and Alzheimer disease: The only method for confirmed AD diagnosis is post-mortem histological evidence of cerebral amyloid beta (Aβ) aggregates in the form of senile neuritic plaques and intraneuronal neurofibrillary tangles composed of hyperphosphorylated tau (Rowan et al., 2007; Sorrentino and Bonavita, 2007).